Finland
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 26.47 M
|
Dec. 31, 2023 | USD 2.11 | 12.72% |
|
Finland |
|
2 |
USD -219.65 K
|
Dec. 31, 2023 | USD 3.39 | 7.41% |
|
Finland |
|
3 |
USD -1.94 M
|
Dec. 31, 2023 | USD 1.05 | -2.11% |
|
Finland |
|
4 |
USD -2.59 M
|
Dec. 31, 2023 | USD 3.48 | 0.09% |
|
Finland |
|
5 |
USD -54.25 M
|
Dec. 31, 2023 | USD 11.16 | -0.17% |
|
Finland |
|
6 |
USD -128.26 M
|
Dec. 31, 2023 | USD 12.42 | 1.35% |
|
Finland |
|
7 |
USD -268.43 M
|
Dec. 31, 2023 | USD 54.50 | 0.21% |
|
Finland |
The Healthcare company in Finland with the highest Net Cash Used Provided By Financing Activities is Faron Pharmaceuticals Oy (LSE: FARN.L) at USD 26.47 M.
The Healthcare company in Finland with the lowest Net Cash Used Provided By Financing Activities is Orion Oyj (Helsinki Stock Exchange: ORNBV.HE) at USD -268.43 M.
The top 10 Healthcare companies in Finland by Net Cash Used Provided By Financing Activities are Faron Pharmaceuticals Oy, Biohit Oyj, Modulight Oyj, Nordhealth AS, Pihlajalinna Oyj, Terveystalo Oyj and Orion Oyj.
The bottom 10 Healthcare companies in Finland by Net Cash Used Provided By Financing Activities are Orion Oyj, Terveystalo Oyj, Pihlajalinna Oyj, Nordhealth AS, Modulight Oyj, Biohit Oyj and Faron Pharmaceuticals Oy.